Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the P13K/Akt pathway

Endothelium: Journal of Endothelial Cell Research

Volumn 11, Issue 5-6, 2004, Pages 247-252

  Yin, Deling ^a   Li, Chuanfu ^a   Kao, Race L ^a   Ha, Tuanzhu ^a   Krishnaswamy, Guha ^a   Fitzgerald, Matthew ^a   Stuart, Charles A ^a  

^a East Tennessee State University   (United States)

Author keywords

Akt; Cell death; Endothelial cell; Fas; Fas ligand; p53

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOPOIETIN 1; ANTINEOPLASTIC AGENT; DOXORUBICIN; FAS ANTIGEN; FAS LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53;

ANGIOGENESIS; ARTICLE; CARDIOTOXICITY; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOPOIETIN-1; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; APOPTOSIS; DOXORUBICIN; ENDOTHELIUM, VASCULAR; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR SUPPRESSOR PROTEIN P53; UMBILICAL VEINS; UP-REGULATION;

EID: 12344334433     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320490904115     Document Type: Article

References (33)

1. Aki T., Yamaguchi K., Fujimiya T., and Mizukami Y. (2003) Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene, 22, 8529-8535.
2. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., and Knaus UG. (2000) Toll-like receptor 2-mediated NF-κB activation requires a RAC I-dependent pathway. Nature Immunology, 1, 533-540.
3. Chao W., Shen Y., Li L., and Rosenzweig A. (2002) Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. Journal of Biological Chemistry, 277, 31639-31645.
4. Clerk A., Cole S.M., Cullingford T.E., Harrison J.G., Jormakka M., and Valks D.M. (2003) Regulation of cardiac myocyte cell death. Pharmacology & Therapeutics, 97, 223-261.
5. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V.L., Culhane A.C. and Williams G.T. (1996) Apoptosis: Molecular regulation of cell death. European Journal of Biochemistry 236, 1-26.
6. Fujikawa K., de Aos Scherpenseel I., Jain S.K., Presman E., Christensen R.A., and Varticovski L. (1999) Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Experimental Cell Research, 253, 663-672.
7. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., and Walsh K. (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation, 101, 660-667.
8. Harfouche R., Gratton J.P., Yancopoulos G.D., Noseda M., Karsan A., and Hussain S.N. (2003) Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB Journal, 17, 1523-1525.
9. Kim I., Kim H.G., Moon S.O., Chae S.W., So J.N., Koh K.N., Ahn B.C., and Koh G.Y. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol-3 kinase/Akt signal transduction pathway. Circulation Research, 86, 24-29.
10. Kim I., Ryu Y.S., Kwak H.J., Ahn S.Y, Oh J.L., Yancopoulos G.D., Gale N.W., and Koh G.Y. (2002) EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB Journal, 16, 1126-1128.
11. Liu X., Chua C.C., Gao J., Chen Z., Landy C.L., Hamdy R., and Chua B.H. (2004) Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. American Journal of Physiology Heart and Circulatory Physiology, 286, H933-H939.
12. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., and Rosenzweig A. (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation, 104, 330-335.
13. Metheny-Barlow L., and Li Y. (2003) The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Research, 13, 309-317.
14. Mishima K., Nariai Y., and Yoshimura Y. (2003) Carboplatin induces Fas (APO-1/CD95)-dependent of human tongue carcinoma cells: Sensitization for apoptosis by upregulation of FADD expression. International Journal of Cancer, 105, 593-600.
15. Muller M., Strand S., Hug H., Heinemann E.M., Walczak H., Hofmann W.J., Stremmel W., Krammer PH., and Galle P.R. (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (Apo-1/Fas (CD95) receptor/ligand system and involves activation of wild-type p53. Journal of Clinical Investigation, 99, 403-413.
16. Nagata S. (1999) Fas ligand-induced apoptosis. Annu. Rev. Genet., 33, 29-55.
17. Nakamura T., Ueda Y., Juan Y., Katsuda S., Takahashi H., and Koh E. (2000) Fas-mediated apoptosis in adriamycin-induced cardomyopathy in rats. Circulation, 102, 572-578.
18. Okuyama M., Yamaguchi S., Nozaki N., Yamaoka M., Shirakabe M., and Tomoike H. (1997) Serum levels of soluble form of Fas molecular in patients with congestive heart failure. American Journal of Cardiology, 79, 1698-1701.
19. Oshimi Y., Oda S., Honda Y., Nagata S., and Miyazaki S. (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Journal of Immunology, 157, 2909-2915.
20. Owen-Schaub L.B., Zhang W., Cusack J.C., Angelo L.S., Santee S.M., Fujiwara T., Roth J.A., Deisseroth A.B., Zhang W.W., Kruzel E., et al. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Molecular and Cellular Biology, 15, 3020-3040.
21. Ren X.H., Zhao J., Pu L., Ling K., Yin D.L., and Pei G. (1998) Differential neurotoxicity of etorphine-like opiates: Lack of correlation with their ability to activate opiate receptors. Toxicon 36, 735-743.
22. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., and Downward J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature, 370, 527-532.
23. Ruiz-Ruiz M., and Lopez-Rivas A. (1999) p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Cell Death and Differentiation, 6, 271-280.
24. Suhara T., Fukuo K., Yasuda O., Tsubakimoto M., Takemura Y., Kawamoto H., Yokoi T., Mogi M., Kaimoto T., and Ogihara T. (2004) Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension, 43, 1208-1213.
25. Suhara T., Mano T., Oliveira B.E., and Walsh K. (2001) Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circulation Research, 89, 13-19.
26. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., and Cohen G.M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. Journal of Biology Chemistry, 274, 5053-5060.
27. Tamura T., Aoyama N., Saya H., Haga H., Futami S., Miyamoto M., Koh T., Ariyasu T., Tachi M., Kasuga M., et al. (1995) Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene, 11, 1939-1946.
28. Tsigkos S., Koutsilieris M., and Papapetropouos A. (2003) Angiopoietins in angiogenesis and beyond. Expert Opinion on Investigational Drugs, 12, 933-941.
29. Valable S., Bellail A., Lesne S., Liot G., Mackenzie E.T., Vivien D., Bernaudin M., and Petit E. (2003) Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis. FASEB Journal, 17, 443-445.
30. Wollert K.C., Heineke J., Westermann J., Ludde M., Fiedler B., Zierhut W., Laurent D., Bauer M.K., Schulze-Osthoff K., and Drexler H. (2000) The cardiac Fas (APO-1/CD95) receptor/Fas ligand system. Relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation, 101, 1172-1178.
31. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. (2000) Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction. Cardiovascular Research, 45, 630-641.
32. Yin D., Mufson R., Wang R., and Shi Y. (1999) Fas-mediated cell death promoted by opioids. Nature, 397, 218.
33. Yin D., Zhang L., Wang R., Radvanyi L., Haudenschild C., Fang Q., Kehry MR., and Shi Y. (1999) Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. Journal of Immunology 163, 4328-4334.